인투셀
16,610KRWMarket close of 10/21 (Wed)
Down -2.06%-350KRWMarket close of 10/21 (Wed)
Preliminary value right after the close — replaced by official KRX data tomorrow morningClose of 10/22 (Thu)16,840KRWUp +1.38%
Preliminary · just after the close · replaced by official KRX data tomorrow morning
- Open
- 17,420
- High
- 18,020
- Low
- 16,420
- Day range
- Day range low 16,420 high 18,020, open 17,420, close 16,610, previous close 16,960
- Volume
- 5×10K shares
- 823.09 million KRW 1.34× the 20-session average
Market close of 10/21 (Wed)
Where it sits in the 1-year range
5%5% of the way up from the lowest close in 1 year (252 sessions) · -76.6% from the high
Usual range
Nothing unusual in the 5 checked items
Free · no sign-inSource from 2021-05-17
Points to check
- Earningsnot verifiedOutside financial data coverage, so not verified
- Daily moveusual range-2.06%-2.06%, 0.5× the usual (20-session average ±3.97%)That day -2.06% · usual ±3.97% · large-move threshold ±7.9%
- Trading valueusual range1.3×823.09 million KRW, 1.3× the 20-session average1.34× the 20-session average · check threshold 3×
The other 3 are within the usual range
- Recent filings0Last 14 days
- Foreign & institutional+700.00 million KRWusual range
- Data date10/21 (Wed)Market close
See the full check report
Same sector · 바이오 R&D
Up +3.03%· 33 of 64 stocks up, preferred shares excluded · trading value 215.2B KRW
| Stock | 20D | Change | Trading value |
|---|---|---|---|
| 알테오젠 | Close over the last 20 sessions -5.5% | Up +3.90% | 60.7B KRW |
| 올릭스 | Close over the last 20 sessions -6.4% | Up +9.53% | 26.1B KRW |
| 디앤디파마텍 | Close over the last 20 sessions -6.0% | Up +6.65% | 22.0B KRW |
| 리가켐바이오 | Close over the last 20 sessions -14.3% | Up +2.00% | 12.9B KRW |
| 프로티나 | Close over the last 20 sessions +35.7% | Up +7.23% | 11.0B KRW |
Schedule
- Next data 10/23 (Fri) after 08:50
Investor flows, financials and valuation are provided for 369 stocks. These stocks account for about 85% of trading value, about 92% of market capitalisation. Coverage status →
For information only, not a solicitation to invest. Investment decisions and their results are your own responsibility.